Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$423,144
+$10,719 QoQ
Shares Held
2,700
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#964
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PHILADELPHIA TRUST CO holds $76,830,601 across 11 Drug Manufacturers - General names. NVS ranks #10 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
150,654 | $37,910,572 | |
| 2 | AMGN |
Amgen Inc
|
36,796 | $13,324,567 | |
| 3 | JNJ |
Johnson & Johnson
|
30,688 | $7,793,831 | |
| 4 | MRK |
Merck & Co., Inc.
|
52,416 | $6,735,456 | |
| 5 | LLY |
ELI LILLY & Co
|
3,859 | $4,628,600 | |
| 6 | GSK |
GSK plc
|
53,680 | $2,813,905 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
25,425 | $1,464,988 | |
| 8 | PFE |
Pfizer Inc
|
37,095 | $893,247 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $423,144 | 2,700 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $412,425 | 2,700 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $372,249 | 2,700 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $346,248 | 2,700 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $326,727 | 2,700 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $300,996 | 2,700 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $264,099 | 2,714 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $312,164 | 2,714 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $288,932 | 2,714 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $262,525 | 2,714 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $274,032 | 2,714 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $276,448 | 2,714 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $273,869 | 2,714 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $277,104 | 3,012 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $273,248 | 3,012 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $228,942 | 3,012 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $254,604 | 3,012 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $264,303 | 3,012 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $280,953 | 3,212 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $262,677 | 3,212 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $293,062 | 3,212 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $274,561 | 3,212 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $303,309 | 3,212 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $279,315 | 3,212 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $280,536 | 3,212 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $264,829 | 3,212 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||